Health
Can Moderna shares rally on higher vaccine efficacy against Delta variant? – ig.com
Covid-19 vaccine maker Moderna’s stock has been on a tear this year, hitting record highs.
- Moderna (Nasdaq: MRNA) share price falls to US$456.76 per share
- The US biotech said it will not exceed its 2021 vaccine production target
- Modernas jab may be more effective against the Delta variant than its rivals shot, a study suggested
- Feeling bullish or…
Continue Reading
-
Noosa News10 hours agoMega-team of heavy horses sets world record at Good Old Days Festival
-
General14 hours agoEnglish springer spaniels Kelly and Milo helping fight dieback in Western Australia
-
General12 hours agoHomicide Squad investigating ‘suspicious’ death of 84yo woman in Sydney suburb of Melonba
-
Noosa News19 hours agoWhat time does the NRL grand final kick off? When is the NRLW grand final?